dr well semaglutide GLP-1² Advanced Weight Loss Therapy GLP-1 Weight Loss Medication -

Oncogene 25 (16), 23042317

The active ingredient in Ozempic and Wegovy is semaglutide, a synthetic version of a hormone known as GLP-1, which the body produces when a person eats

Abbreviations AD: Alzheimers disease CCK: Cholecystokinin CNS: Central nervous system CRF: Corticotropin-releasing factor DPP4i: Dipeptidyl peptidase-4 inhibitor FDA: Food and Drug Administration FOS: Fructooligosaccharides GERD: Gastroesophageal reflux disease GI: Gastrointestinal GIP: Glucose-dependent insulinotropic polypeptide GLP-1: Glucagon-like peptide-1 GLP-1 RA: Glucagon-like peptide-1 receptor agonist IPPW: Isolated pyloric pressure wave MMC: Migrating motor complex PYY: Peptide YY RCT: Randomized controlled trial SCFA: Short chain fatty acid T2DM: Type two diabetes mellitus References Yao H, et al

What to Expect Over Time Weeks 12: Decrease in inflammation and discomfort Early improvements in digestion and gut comfort (oral form) Weeks 36: Improved tissue repair and mobility Enhanced recovery and energy levels Weeks 612+: Long-term improvements in joint, tendon, and muscle strength Sustained gut health and systemic support Results vary depending on condition, severity, and consistency of use

NADH inhibition of SIRT1 links energy state to transcription during time-restricted feeding